CVS Health (CVS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Recently, Zacks.com users have been paying close attention to CVS Health (CVS). This makes it worthwhile to examine what the stock has in store.
Ensign, Encompass Health, Tenet Healthcare and CVS Health look primed for Q1 2026 earnings beats as occupancy, revenue gains and rate hikes help offset rising costs.
UnitedHealthcare and Aetna detailed progress toward industry commitments aimed at reducing administrative burdens and speeding patients' access to care.
CVS Health (CVS) concluded the recent trading session at $76.43, signifying a -1.2% move from its prior day's close.
CVS Health (CVS) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
More than 500 CVS Health drivers and warehouse workers at the healthcare conglomerate's Fredericksburg, Virginia distribution center have voted to authorize a strike on May 1, the International Brotherhood of Teamsters said on Thursday.
CVS Health (CVS) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
In the latest trading session, CVS Health (CVS) closed at $78.09, marking a -1.56% move from the previous day.
The Trump administration will increase average Medicare Advantage payments by 2.48%, or more than $13 billion, in 2027, according to CMS. That's significantly higher than the proposed payment rate hike of 0.09% that the government floated in January.
CVS Health is facing some headwinds, which have adversely affected its stock price. Rising costs are putting pressure on its profits.
Zacks.com users have recently been watching CVS Health (CVS) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.